Skip to content

TIMCIs: A Hybrid Type 2 Study of Next-generation Pulse Oximeters

A Study of Next-generation Pulse Oximeters to Support the Integrated Management of Childhood Illnesses in Primary Care Settings. A Mixed Methods Type 2 Effectiveness-implementation Study Measuring the Performance and Feasibility, of Multimodal Pulse Oximeter Devices by Primary Care Providers

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05527990
Enrollment
650
Registered
2022-09-06
Start date
2022-03-20
Completion date
2023-12-31
Last updated
2023-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focus of Study: Accurate Clinical Measurement and Diagnosis

Brief summary

This study aims to provide evidence on next-generation clinical measurement tools through a mixed methods diagnostic accuracy and implementation study in Kenya, Senegal, Tanzania, and Uttar Pradesh, India.

Detailed description

Performance and feasibility of photoplethysmograph (PPG)-derived clinical measurement tools (medical device and smartphone-based screening technologies) by primary care providers will be assessed using a type 2 hybrid design to conduct a mixed methods diagnostic accuracy and implementation study. The diagnostic accuracy study will consist of 3 components to achieve the primary and secondary objectives: 1) a usability assessment of observed user-product interactions and a system usability score, 2) measurement of multimodal PO device performance through comparison against a reference standard, and 3) caregiver/provider acceptability through semi-structured interviews. The observational implementation (OI) study consists of 3 components to achieve the primary and secondary objectives: 1) a human-centered design workshop, 2) an observational study to evaluate the feasibility of implementing an approved multimodal PO device in clinical care, and 3) semi-structured in-depth interviews to assess provider and caregiver acceptability and adaptation. The interventions for this study are PPG-derived clinical measurement tools that measure oxygen saturation (SpO2), pulse rate, respiratory rate, and/or temperature. The interventions will also be compared to a reference standard for the different clinical measurements

Interventions

DEVICEMultimodal PO

Mixed methods diagnostic accuracy and implementation of multimodal PO

Sponsors

UNITAID
CollaboratorOTHER
Bill and Melinda Gates Foundation
CollaboratorOTHER
PATH
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 59 Months
Healthy volunteers
No

Inclusion criteria

* Children 0 - 59 months for whom caregivers provide consent to participate in the research study, following completion of clinical consultation * Consulting for a respiratory illness, or reported to have a respiratory illness when attending for a routine visit as an outpatient (e.g., vaccination, growth, or chronic disease monitoring)

Exclusion criteria

* Children in the immediate post-natal period or first day of life * Attending for a consultation related to trauma only (including new and follow-up presentations for burns, injuries, wounds) * Admitted within an inpatient part of the facility (including neonates delivered at the facility admitted with their mother) * Children who are critically ill, requiring emergency treatment, or received a recommendation of immediate referral during clinical consultation

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy: Performance of clinical measurement tools19 weeksTo determine the performance of PPG-derived clinical measurement tools (medical device and smartphone-based screening technologies) compared to an accepted reference standard, among children 0-59 months seeking care at the primary care level.
Observational implementation: multimodal (MM) operational feasibility16 weeksTo evaluate the operational feasibility of implementing an approved next generation pulse oximeter at the primary care level.

Secondary

MeasureTime frameDescription
DA: Data repository19 weeksTo create an open-source data repository for future research on PPG-derived clinical measurement tools for children.
DA: MM Usability2 weeksTo measure the usability of multimodal PO devices, measuring pulse oximetry and respiratory rate in addition to other relevant clinical measurements, by healthcare providers at the primary care level.
OI: MM co-design1 weekTo co-design integration of an approved multimodal PO device within existing IMCI practices, mapping current and future state workflows, prioritizing outcomes, and determining training needs.
OI: MM/clinical measurement system requirements16 weeksTo explore future multimodal PO device and smartphone based clinical measurement product concepts and prototypes to further define the user and health system requirements for potential device integration within integrated management of childhood illness (IMCI) care practices, among country stakeholders and healthcare providers.
DA: MM Acceptability21 weeksTo assess the acceptability of multimodal PO devices among healthcare providers and caregivers at the primary care level.

Countries

Kenya

Contacts

Primary ContactHelen Storey, PhD.
hstorey@path.org510-541-4160
Backup ContactMegan Horlacher
mhorlacher@path.org7345365674

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026